Israeli Life Sciences Database

TEL AVIV, Israel, Jan. 10, 2019 /PRNewswire/ -- Perflow Medical, an Israeli-based medtech company focused on next-generation neuro-interventional devices, today announced the issuance of four international patents that expand the global intellectual property (IP) coverage for the novel Stream(TM)... Read more ››

By: PR Newswire Association LLC. - 10 Jan 2019

Related companies: Perflow Medical Ltd.

Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient

By: Nasdaq / GlobenewsWire - 09 Jan 2019

Related companies: Pluristem Therapeutics Inc

Anchiano Therapeutics Announces Filing of F-1 Registration Statement for U.S. Initial Public Offering

By: Nasdaq / GlobenewsWire - 07 Jan 2019

Related companies: Anchiano Therapeutics, Inc.

Microbot Medical Announces FDA Pre-Submission Milestones for 2019

By: Nasdaq / GlobenewsWire - 07 Jan 2019

Related companies: Microbot Medical Inc. | Microbot Medical Ltd.

Pluristem Concludes Positive Meeting with FDA on Development Plan for Acute Radiation Syndrome

By: Nasdaq / GlobenewsWire - 03 Jan 2019

Related companies: Pluristem Therapeutics Inc

Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2018

By: Nasdaq / GlobenewsWire - 02 Jan 2019

Related companies: Kamada Ltd.

AIT Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer

By: Nasdaq / GlobenewsWire - 02 Jan 2019

Related companies: AIT Therapeutics Inc.

AIT Nearing Definitive Agreement to License Commercial Rights of Its Novel Ventilator Compatible Nitric Oxide Generator and Delivery System for Use in the Hospital Setting in the United States and a Second Country

By: Nasdaq / GlobenewsWire - 28 Dec 2018

Related companies: AIT Therapeutics Inc.

Foamix Submits New Drug Application to U.S. FDA Seeking Approval of FMX101 in Treatment of Moderate-to-Severe Acne

By: Nasdaq / GlobenewsWire - 21 Dec 2018

Related companies: Foamix Pharmaceuticals Ltd.

S1 Biopharma Granted Patents for Lorexys(TM) in Europe and Asia for Treatment of Hypoactive Sexual Desire Disorder

NEW YORK, Dec. 20, 2018 /PRNewswire/ -- S1 Biopharma, Inc. (S1) announced today that the European Patent Office has granted a European Patent for the Company's proprietary dual-mechanistic therapy Lorexys(TM) for hypoactive sexual desire disorder. A corresponding patent was previously... Read more ››

By: PR Newswire Association LLC. - 20 Dec 2018

Evogene and TMG Announce Collaboration to Develop Nematode Resistant Soybean through Genome Editing

By: Nasdaq / GlobenewsWire - 18 Dec 2018

Related companies: Evogene Ltd.

InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems

By: Nasdaq / GlobenewsWire - 18 Dec 2018

Related companies: InspireMD, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 »

Looking for companies outside of Israel?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

February 2019
- Zurich: 12th Annual European Life Sciences CEO Forum
March 2019
- Tokyo: BIO Asia International Conference
- Singapore: Phar-East 2019

See Events »

Add an Event »

Latest company news

InspireMD Announces Fourth Quarter 2018 Financial Results
19 Feb 2019 (Nasdaq / GlobenewsWire)

RedHill Biopharma to Present at the 8th Annual SVB Leerink Healthcare Conference
19 Feb 2019 (Nasdaq / GlobenewsWire)

VBL Therapeutics to Present Data on its Novel VB-600 Platform at Keystone Conference on February 26
19 Feb 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Israel?

Partners

Upcoming Life Sciences Events

Latest company news